The North American Creatinine Measurement Market is expected to reach US$ 269.75 million in 2027 from US$ 148.79 million in 2019

Ads

You May Also Like

Merit Medical Announces Pricing of Public Offering of Common Stock

SOUTH JORDAN, Utah, July 25, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ:MMSI) ...

resTORbio Announces Formation of Clinical Advisory Board

Esteemed Experts Engaged as Company Advances Clinical Development Program Phase 2b Data for Lead ...